Navigation Links
VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
Date:8/18/2008

y disclosed in the Company's July 29, 2008 press release reduced earnings per share by three cents, from $0.56 to $0.53.

The condensed consolidated statement of operations for the three and six months ended June 30, 2008, along with other related disclosures in the accompanying notes, is contained in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 18, 2008.

Business Outlook

The Company is changing its earning guidance solely due to changes in stock-based compensation expense. VNUS currently expects full year stock based pre-tax compensation expense to increase by $762,000 or approximately four-and-a-half cents per share and range from $4.2 million to $4.6 million. Stock-based pre-tax compensation expense through the six months ended June 30, 2008 was $2.2 million.

Third quarter net income is expected to range from $0.9 million to $1.8 million or income of $0.06 to $0.11 per share. Adjusted EBITDA guidance for the third quarter remains unchanged at $2.0 million to $3.0 million. VNUS currently expects its full-year 2008 net income to range from approximately $12.4 million to $13.4 million, or income of $0.73 to $0.80 per share. VNUS expects Adjusted EBITDA to remain unchanged for the full year and range from $17.0 million to $18.1 million.

Non-GAAP Financial Information:

VNUS' management evaluates and makes operating decisions using various operating measures, including revenue growth and adjusted earnings before interest, taxes, depreciation and amortization, and non-cash charges for stock-based compensation (Adjusted EBITDA). The Company believes that these non-GAAP measures, when presented in conjunction with the comparable GAAP measures, are useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows
'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arno Therapeutics Announces Second Quarter 2008 Financial Results
2. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
3. Yongye Biotechnology International Announces Second Quarter Results
4. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
5. China Kangtai Cactus Biotech Announces Record Second Quarter Results
6. AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
7. SPO Medical Reports Second Quarter 2008 Results
8. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
9. China Biologic Products Reports Second Quarter 2008 Results
10. Neuralstem Reports Second Quarter Financial Results and Highlights
11. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Genzyme Corporation and Middleton-based Bone Care International Inc. ... fast-tracked their proposed merger. , ,Genzyme and Bone Care have ... Bone Care in an all-cash transaction valued at $33.00 per ... approval by Bone Care's shareholders at a meeting ...
... 151 bypass around Fond du Lac, Wis., opens later ... on a bridge like no other in the country. ... could help to speed bridge-deck construction Externally, the ... the concrete deck reinforced with a novel fiber-reinforced polymer ...
... Commitment. These are the 4 C's that I learned early ... always felt that each "C" was equally important; the folks ... with thick wallets, and so forth. Until a few weeks ... for an organization I love. It was exhilarating: we addressed ...
Cached Biology Technology:Polymer grid technology a boon for bridges 2Polymer grid technology a boon for bridges 3Are boards broken? 2
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
(Date:11/21/2014)... C-Labs LLC, a leading provider of remote ... today announced the appointment of John Traynor ... strategic advisor to the firm, Mr. Traynor will now ... based out of the C-Labs office in ... Muench , Chief Executive Officer. Photo - ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... often thought of as a domesticated animal, one that may ... the wilderness of North America, are thought of as conducting ... the journal Nature Climate Change suggests that there ... and change in climate played a role in their evolution. ...
... macrophages, the immune system,s healthy scavenger cells, play a key ... other areas of the body, according to research to be ... Biology annual meeting in New Orleans. The researchers, ... Health & Science University (OHSU) in Portland followed the work ...
... in Alzheimer,s disease (AD) has focused on whether the protein ... cause of the disease. But George Bloom, Ph.D., and ... hypothesis: much earlier interactions between the two proteins them drive ... (CCR). Dr. Bloom will present additional evidence supporting ...
Cached Biology News:Climate change will endanger caribou habitat, study says 2Spontaneous fusion with macrophages empowers cancer cells to spread 2Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimer's disease 2
... Partek Genomics Solution is a comprehensive ... data visualization specifically designed to reliably ... for high-dimensional genomic studies containing thousands ... fast, memory efficient and will analyze ...
Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
Intestinal Epithelium Differentiation Environment...
Biology Products: